Our data are in line with findings implicating NET protease–processed IL-1β in gout attacks (56) and of neutrophil protease-generated IL-33 in acute lung injury (18), pointing to neutrophil proteases generating NET-associated IL-33 with high interferogenic activity in the context of lupus. This evidence concerns the gene IL33 and systemic lupus erythematosus.